Logo image of DOCN

DIGITALOCEAN HOLDINGS INC (DOCN) Stock Fundamental Analysis

USA - NYSE:DOCN - US25402D1028 - Common Stock

36.98 USD
+1.29 (+3.61%)
Last: 9/15/2025, 4:11:13 PM
36.98 USD
0 (0%)
After Hours: 9/15/2025, 4:11:13 PM
Fundamental Rating

5

Taking everything into account, DOCN scores 5 out of 10 in our fundamental rating. DOCN was compared to 86 industry peers in the IT Services industry. DOCN has only an average score on both its financial health and profitability. DOCN is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year DOCN was profitable.
In the past year DOCN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DOCN reported negative net income in multiple years.
In the past 5 years DOCN always reported a positive cash flow from operatings.
DOCN Yearly Net Income VS EBIT VS OCF VS FCFDOCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

DOCN has a Return On Assets of 7.35%. This is in the better half of the industry: DOCN outperforms 76.74% of its industry peers.
DOCN has a better Return On Invested Capital (6.93%) than 62.79% of its industry peers.
Industry RankSector Rank
ROA 7.35%
ROE N/A
ROIC 6.93%
ROA(3y)1.65%
ROA(5y)-1.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DOCN Yearly ROA, ROE, ROICDOCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

DOCN has a better Profit Margin (15.18%) than 91.86% of its industry peers.
With an excellent Operating Margin value of 15.66%, DOCN belongs to the best of the industry, outperforming 84.88% of the companies in the same industry.
DOCN has a Gross Margin of 59.67%. This is amongst the best in the industry. DOCN outperforms 80.23% of its industry peers.
DOCN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.66%
PM (TTM) 15.18%
GM 59.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y2.79%
DOCN Yearly Profit, Operating, Gross MarginsDOCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DOCN is destroying value.
DOCN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DOCN has been increased compared to 5 years ago.
The debt/assets ratio for DOCN has been reduced compared to a year ago.
DOCN Yearly Shares OutstandingDOCN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DOCN Yearly Total Debt VS Total AssetsDOCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

DOCN has an Altman-Z score of 1.81. This is not the best score and indicates that DOCN is in the grey zone with still only limited risk for bankruptcy at the moment.
DOCN's Altman-Z score of 1.81 is on the low side compared to the rest of the industry. DOCN is outperformed by 62.79% of its industry peers.
The Debt to FCF ratio of DOCN is 15.86, which is on the high side as it means it would take DOCN, 15.86 years of fcf income to pay off all of its debts.
DOCN's Debt to FCF ratio of 15.86 is in line compared to the rest of the industry. DOCN outperforms 45.35% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 15.86
Altman-Z 1.81
ROIC/WACC0.92
WACC7.55%
DOCN Yearly LT Debt VS Equity VS FCFDOCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 2.27 indicates that DOCN has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.27, DOCN is doing good in the industry, outperforming 66.28% of the companies in the same industry.
DOCN has a Quick Ratio of 2.27. This indicates that DOCN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.27, DOCN is in the better half of the industry, outperforming 67.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 2.27
DOCN Yearly Current Assets VS Current LiabilitesDOCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

8

3. Growth

3.1 Past

DOCN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.67%, which is quite impressive.
The Earnings Per Share has been growing by 145.35% on average over the past years. This is a very strong growth
DOCN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.29%.
DOCN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.09% yearly.
EPS 1Y (TTM)20.67%
EPS 3Y145.35%
EPS 5YN/A
EPS Q2Q%22.92%
Revenue 1Y (TTM)13.29%
Revenue growth 3Y22.13%
Revenue growth 5Y25.09%
Sales Q2Q%13.62%

3.2 Future

Based on estimates for the next years, DOCN will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.98% on average per year.
The Revenue is expected to grow by 13.41% on average over the next years. This is quite good.
EPS Next Y10.65%
EPS Next 2Y6.57%
EPS Next 3Y9.98%
EPS Next 5YN/A
Revenue Next Year14.71%
Revenue Next 2Y14.61%
Revenue Next 3Y14.97%
Revenue Next 5Y13.41%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DOCN Yearly Revenue VS EstimatesDOCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
DOCN Yearly EPS VS EstimatesDOCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.12 indicates a rather expensive valuation of DOCN.
72.09% of the companies in the same industry are more expensive than DOCN, based on the Price/Earnings ratio.
DOCN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
Based on the Price/Forward Earnings ratio of 16.96, the valuation of DOCN can be described as correct.
68.60% of the companies in the same industry are more expensive than DOCN, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.73. DOCN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.12
Fwd PE 16.96
DOCN Price Earnings VS Forward Price EarningsDOCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

DOCN's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DOCN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 35.86
EV/EBITDA 16.9
DOCN Per share dataDOCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
DOCN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.61
PEG (5Y)N/A
EPS Next 2Y6.57%
EPS Next 3Y9.98%

0

5. Dividend

5.1 Amount

DOCN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DIGITALOCEAN HOLDINGS INC

NYSE:DOCN (9/15/2025, 4:11:13 PM)

After market: 36.98 0 (0%)

36.98

+1.29 (+3.61%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03/amc
Inst Owners65.32%
Inst Owner Change5.49%
Ins Owners0.95%
Ins Owner Change-0.7%
Market Cap3.37B
Analysts75.79
Price Target41.54 (12.33%)
Short Float %14.81%
Short Ratio4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.75%
Min EPS beat(2)23.58%
Max EPS beat(2)23.93%
EPS beat(4)4
Avg EPS beat(4)28.77%
Min EPS beat(4)23.58%
Max EPS beat(4)41.38%
EPS beat(8)8
Avg EPS beat(8)22.77%
EPS beat(12)11
Avg EPS beat(12)23.98%
EPS beat(16)14
Avg EPS beat(16)25.95%
Revenue beat(2)0
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-1.01%
Max Revenue beat(2)-0.95%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-1.07%
Max Revenue beat(4)0.2%
Revenue beat(8)3
Avg Revenue beat(8)-0.44%
Revenue beat(12)4
Avg Revenue beat(12)-0.65%
Revenue beat(16)5
Avg Revenue beat(16)-0.75%
PT rev (1m)6.48%
PT rev (3m)6.48%
EPS NQ rev (1m)1.11%
EPS NQ rev (3m)3.66%
EPS NY rev (1m)6.96%
EPS NY rev (3m)8.54%
Revenue NQ rev (1m)0.43%
Revenue NQ rev (3m)1.36%
Revenue NY rev (1m)0.98%
Revenue NY rev (3m)0.98%
Valuation
Industry RankSector Rank
PE 17.12
Fwd PE 16.96
P/S 4.04
P/FCF 35.86
P/OCF 11.18
P/B N/A
P/tB N/A
EV/EBITDA 16.9
EPS(TTM)2.16
EY5.84%
EPS(NY)2.18
Fwd EY5.9%
FCF(TTM)1.03
FCFY2.79%
OCF(TTM)3.31
OCFY8.95%
SpS9.15
BVpS-1.92
TBVpS-6.96
PEG (NY)1.61
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.35%
ROE N/A
ROCE 8.72%
ROIC 6.93%
ROICexc 9.36%
ROICexgc 15.96%
OM 15.66%
PM (TTM) 15.18%
GM 59.67%
FCFM 11.27%
ROA(3y)1.65%
ROA(5y)-1.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y2.79%
F-Score7
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 15.86
Debt/EBITDA 5.79
Cap/Depr 163.25%
Cap/Sales 24.9%
Interest Coverage 179.62
Cash Conversion 117.02%
Profit Quality 74.24%
Current Ratio 2.27
Quick Ratio 2.27
Altman-Z 1.81
F-Score7
WACC7.55%
ROIC/WACC0.92
Cap/Depr(3y)124.77%
Cap/Depr(5y)130.2%
Cap/Sales(3y)21.36%
Cap/Sales(5y)25.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.67%
EPS 3Y145.35%
EPS 5YN/A
EPS Q2Q%22.92%
EPS Next Y10.65%
EPS Next 2Y6.57%
EPS Next 3Y9.98%
EPS Next 5YN/A
Revenue 1Y (TTM)13.29%
Revenue growth 3Y22.13%
Revenue growth 5Y25.09%
Sales Q2Q%13.62%
Revenue Next Year14.71%
Revenue Next 2Y14.61%
Revenue Next 3Y14.97%
Revenue Next 5Y13.41%
EBIT growth 1Y63.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.62%
EBIT Next 3Y33.49%
EBIT Next 5Y25.38%
FCF growth 1Y-10.19%
FCF growth 3Y58.83%
FCF growth 5YN/A
OCF growth 1Y37.51%
OCF growth 3Y28.54%
OCF growth 5Y47.94%